Early biochemical detection of pre-eclampsia: The role of placental proteins

Immuno-Analyse et Biologie Specialisee

Volumn 19, Issue 1, 2004, Pages 47-53

  Bersinger, Nick A ^a   Ødegård, Rønnaug ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Early pregnancy; PAPP A; Placenta; Pre eclampsia

Indexed keywords

ACTIVIN A; BIOLOGICAL MARKER; GROWTH FACTOR; INHIBIN A; PLACENTA PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE;

EID: 1242338151     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2003.12.005     Document Type: Article

References (38)

1. Ahmed A., Dunk C., Ahman S., Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) and soluble Flt-1 by oxygen - a review. Tropho Res (Placenta). 14:2000;S16-S24.
2. Aquilina J., Barnett A., Thompson O., Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for pre-eclampsia. Am J Obstet Gynecol. 181:1999;131-136.
3. Austgulen R., Lien E., Vince G., Redman C.W. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 71:1997;53-58.
4. 1-glycoprotein in women with suppressed, normal and stimulated follicular maturation. Gynecol Endocrinol. 12:1998;231-241.
5. Bersinger N.A., Ødegård R.A. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand. 83:2004;37-45.
6. Bersinger N.A., Brandenberger A.W., Birkhäuser M.H. Endometrial and placental protein markers and ovarian steroids in serum during in vitro fertilisation cycles. Hum Reprod. 10:1995;2149-2154.
7. Bersinger N.A., Marguerat P., Pescia G., Schneider H. Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first trimester serum determinations, and stability studies. Reprod Fertil Dev. 7:1995;1419-1423.
8. Bersinger N.A., Zakher A., Huber U., Pescia G., Schneider H. A sensitive immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Arch Gynecol Obstet. 256:1995;185-192.
9. Bersinger N.A., Smarason A.K., Muttukrishna S., Groome N.P., Redman C.W. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A, and soluble E-selectin. Hypertens Preg. 22:2003;45-55.
10. Bischof P. Placental proteins: pregnancy-associated plasma protein A. Contrib Gynecol Obstet. 12:1984;41-73.
11. 1-glycoprotein as a screening test for at-risk pregnancies. Am J Obstet Gynecol. 141:1981;499-502.
12. Chard T. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul. 4:1994;91-100.
13. Cuckle H., Sehmi I., Jones R. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol. 105:1998;1101-1103.
14. Friedman S.A., Schiff E., Emeis J.J., Dekker G.A., Sibai B.M. Biochemical corroboration of endothelial involvement in severe pre-eclampsia. Am J Obstet Gynecol. 172:1995;202-203.
15. Giudice L.C., Martina N.A., Crystal R.A., Tazuke S., Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol. 176:1997;751-758.
16. Heyl W., Handt S., Reister F., Gehlen J., Schroder W., Mittermayer C., et al. Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1 beta cause endothelial activation. Eur J Obstet Gynecol Reprod Biol. 86:1999;35-41.
17. Howell R.J., Economides D., Teisner B., Farkas A.G., Chard T. Placental protein 12 and 14 in pre-eclampsia. Acta Obstet Gynecol Scand. 68:1989;237-240.
18. Hughes G., Bischof P., Wilson G., Smith R., Klopper A. Assay of placental protein to determine fetal risk. Br Med J. 280:1980;671-673.
19. Iino K., Sjoberg J., Seppala M. Elevated circulating levels of a decidual protein, placental protein 12, in pre-eclampsia. Obstet Gynecol. 68:1986;58-60.
20. Khaliq A., Dunk C., Jiang J., Shams M., Li X.F., Avecedo C., et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest. 79:1999;151-170.
21. Krauss T., Kuhn W., Lakoma C., Augustin H.G. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of pre-eclampsia. Am J Obstet Gynecol. 177:1997;443-449.
22. Lewitt M.S., Scott F.P., Clarke N.M., Baxter R.C. Developmental regulation of circulating insulin-like growth factor binding proteins in normal pregnancies and in pre-eclampsia. Prog Growth Factor Res. 6:1995;475-480.
23. Malek A., Sager R., Lang A.B., Schneider H. Protein transport across the in vitro perfused human placenta. Am J Reprod Immunol. 38:1997;263-271.
24. Muttukrishna S., Knight P.G., Groome N.P., Redman C.W., Ledger W.L. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet. 349:1997;1285-1288.
25. Muttukrishna S., North R.A., Morris J., Schellenberg J.C., Taylor R.S., Asselin J., et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod. 15:2000;1640-1645.
26. Raty R., Koskinen P., Alanen A., Irjala K., Matinlauri I., Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free β-hCG levels. Prenatal Diagn. 19:1999;122-127.
27. Redman C.W., Sacks G.P., Sargent I.L. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 180:1999;499-506.
28. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 161:1989;1200-1204.
29. Rutanen E., Menabawey M., Isaka K., Bohn H., Chard T., Grudzinskas J.G. Synthesis of placental protein 12 by decidua from early pregnancy. J Clin Endocrinol Metab. 63:1986;675-679.
30. Sebire N.J., Roberts L., Noble P., Wallace E., Nicolaides K.H. Raised maternal serum inhibin A concentration at 10-14 weeks gestation is associated with pre-eclampsia. Br J Obstet Gynaecol. 107:2000;795-797.
31. Silver H.M., Lambert G.M., Star J.A., Hogan J., Canick J.A. Comparison of maternal serum total activin A and inhibin A in normal, pre-eclamptic, and non-proteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol. 180:1999;1131-1137.
32. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., Connor J.M. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 87:2002;1762-1767.
33. Su Y.N., Lee C.N., Cheng W.F., Shau W.Y., Chow S.N., Hsieh F.J. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol. 97:2001;898-904.
34. Suefuiji H., Ogawa H., Yasue H., Sakamoto T., Miyao Y., Kaikita K., et al. Increased plasma level of soluble E-selectin in acute myocardial infarction. Am Heart J. 140:2000;243-248.
35. Toop K., Klopper A. Concentration of pregnancy-associated plasma protein A (PAPP-A) in patients with pre-eclamptic toxaemia. Placenta. 4:(Suppl):1981;167-174.
36. Torry D.S., Wang H.S., Wang T.H., Caudle M.R., Torry R.J. Pre-eclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 179:1998;1539-1544.
37. Wald N.J., Stone R., Cuckle H.S., Grudzinskas J.G., Barkai G., Brambati B., et al. First trimester concentrations of pregnancy-associated plasma protein A and placental protein 14 in Down's syndrome. Br Med J. 305:1992;28.
38. Westergaard J.G., Teisner B. Pregnancy-associated plasma protein A in normal and abnormal late pregnancy. Grudzinskas J.G., Teisner B., Seppala M. Pregnancy proteins. 1982;345-354 Academic Press, Sydney.